🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a two-part study to evaluate the safety and tolerability of suprath...
Status
Completed
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02165332
The purpose of this study is to determine the safety, tolerability, and pha...
Status
Completed
Location
ICON San Antonio
Start Date
2025-02-10
Trial ID
NCT06746402
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of ibrut...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02271438
Treatments Being Tested
This will be a Phase 1, single-center, 2-part study in healthy subjects. Pa...
Status
Terminated
Location
Nucleus Network Melbourne
Start Date
2023-04-17
Trial ID
NCT05758818
Treatments Being Tested
Two-Part, Randomized, Placebo and Active-Controlled, Double-Blind, Thorough...
Status
Completed
Location
PRA-Groningen
Start Date
2016-01
Trial ID
NCT02650479
Treatments Being Tested
Since 2005, FDA has required almost all new drugs be tested for their abili...
Status
Completed
Location
Spaulding Clinical Research
Start Date
2023-03-21
Trial ID
NCT05716854
The primary objective of this study was to investigate whether there is a c...
Status
Completed
Location
Universitätsherzzentrum Freiburg - Bad Krozingen
Start Date
2018-05-17
Trial ID
NCT03504982
Treatments Being Tested
This study is comprised of two parts. The purpose of the first part of this...
Status
Completed
Location
Altasciences Clinical Kansas, Inc
Start Date
2022-06-22
Trial ID
NCT05478278
Treatments Being Tested
The primary objective of this study is to evaluate the effect of suprathera...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-02
Trial ID
NCT02833831
Treatments Being Tested
Two-part Phase 1 study to assess the effect of single therapeutic and supra...
Status
Completed
Location
QPS Netherlands B.V.
Start Date
2019-02-14
Trial ID
NCT03832452
Treatments Being Tested